GSK

News

First-quarter sales strength buoys new GSK CEO Miels

GSK has had a solid start to 2026, with revenues rising ahead of analyst expectations in the first full quarter under new CEO Luke Miels.

News

GSK eyes October FDA verdict on chronic hep B drug

GSK's antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, has started a speedy FDA review that should deliver a verdict by 26th October.

News

GSK/Tesaro claim denied in Jemperli lawsuit with AnaptysBio

A court ruling in the US has delivered a setback for GSK and its Tesaro subsidiary in their dispute with AnaptysBio over cancer drug Jemperli.

News

Multiple myeloma drug Blenrep backed for wider NHS use

The revitalisation of GSK's Blenrep has continued with the news that the NHS in England can use the BCMA-targeting multiple myeloma drug more widely.

News

Data backs GSK's ovarian cancer blockbuster hopes

GSK's B7-H4-targeting ADC Mo-Rez chalks up impressive results in ovarian and endometrial cancer, prompting a major phase 3 trials programme.

News

Meningitis outbreak in UK prompts call to widen vaccination

A UK patient group is calling for changes to the decade-old meningitis vaccination programme, after an outbreak in Kent killed two young people.

First-quarter sales strength buoys new GSK CEO Miels

GSK eyes October FDA verdict on chronic hep B drug

GSK/Tesaro claim denied in Jemperli lawsuit with AnaptysBio

Multiple myeloma drug Blenrep backed for wider NHS use

Data backs GSK's ovarian cancer blockbuster hopes

Meningitis outbreak in UK prompts call to widen vaccination

Avalyn seeks $300m from its IPO

Discover a new era of healthcare panel engagement: Grounded ...

GSK

Editor's Picks